Lcfa-01

Phase 1

MMassachusetts General Hospital

Lcfa-01 is one of 20 therapeutic programs targeting Bacterial Vaginosis. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Bacterial VaginosisRecruiting

Bacterial VaginosisPhase 1

Recruiting

Competition

Competitive Landscape

65 competitors in Bacterial Vaginosis

#DrugCompanyPhaseTrials

Flagyl

DDePuy Orthopaedics

Approved

25 2

Acanya

Pfizer

Approved

3 3

Decadron

AAspen Global Incorporated

Approved

—4

Amoxil

GGlobal Antibiotics Research and Development Partnership

Mycostatin

Lactobacillus Acidophilus

UUniversiteit Antwerpen

Approved

1 7

Tindamax

MMission Pharmacal

Phase 3

3 8

Lactoferrin

UUniversità degli Studi di Ferrara

Phase 3

1 9

Conventional

PPopulation Health Research Institute

Phase 3

1 10

Lactoserum

Sanofi

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Phase 1Recruiting

Bacterial Vaginosis

NCT07514416

Clinical

Trials by Indication[1]

Bacterial Vaginosis1 trial

A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of LCFA-01, an Intravaginal Product, in Healthy Participants for Bacterial Vaginosis Treatment

Recruiting·MMassachusetts General Hospital·Phase 1·NCT07514416·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Lcfa-01. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Lcfa-01. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Massachusetts General Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 1[1]
Company: MMassachusetts General Hospital

Lcfa-01

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q3 2026

Trials by Indication[1]

Bacterial Vaginosis1 trial

References

Drug Info

Quick Facts

Related News